Published in Stroke on February 01, 2002
Alteplase for stroke: money and optimistic claims buttress the "brain attack" campaign. BMJ (2002) 5.59
Recombinant tissue plasminogen activator for acute ischaemic stroke: an updated systematic review and meta-analysis. Lancet (2012) 4.66
Thrombolysis for acute ischemic stroke: results of the Canadian Alteplase for Stroke Effectiveness Study. CMAJ (2005) 2.36
Thrombolysis for acute ischaemic stroke. Cochrane Database Syst Rev (2014) 1.76
Intravenous thrombolysis in acute ischaemic stroke: from trial exclusion criteria to clinical contraindications. An international Delphi study. J Neurol Neurosurg Psychiatry (2007) 1.36
Graphic reanalysis of the two NINDS-tPA trials confirms substantial treatment benefit. Stroke (2010) 1.05
Alteplase for the treatment of acute ischaemic stroke: NICE technology appraisal guidance. Heart (2007) 0.96
Expansion of U.S. emergency medical service routing for stroke care: 2000-2010. West J Emerg Med (2014) 0.94
Proteomic Protease Substrate Profiling of tPA Treatment in Acute Ischemic Stroke Patients: A Step Toward Individualizing Thrombolytic Therapy at the Bedside. Transl Stroke Res (2010) 0.94
A new look at glutamate and ischemia: NMDA agonist improves long-term functional outcome in a rat model of stroke. Future Neurol (2011) 0.89
Current perspectives on the use of intravenous recombinant tissue plasminogen activator (tPA) for treatment of acute ischemic stroke. Vasc Health Risk Manag (2014) 0.88
Chloride channels in stroke. Acta Pharmacol Sin (2012) 0.84
Hemorrhage rates and outcomes when using up to 100 mg intra-arterial t-PA for thrombolysis in acute ischemic stroke. Interv Neuroradiol (2010) 0.84
Admission clinical characteristics and early clinical outcomes among acute ischemic stroke patients. J Biomed Res (2012) 0.83
Advanced imaging application for acute ischemic stroke. Emerg Radiol (2004) 0.81
Imaging of acute stroke prior to treatment: current practice and evolving techniques. Br J Radiol (2014) 0.81
Pharmaco-proteomics opportunities for individualizing neurovascular treatment. Neurol Res (2013) 0.80
Magnetic Resonance Imaging in Acute Ischemic Stroke Patients with Mild Symptoms: An Opportunity to Standardize Intravenous Thrombolysis. J Stroke Cerebrovasc Dis (2015) 0.80
[Implementation of thrombolysis in acute stroke--10-year results of the Innsbruck stroke registry]. Wien Klin Wochenschr (2009) 0.78
What to do With Wake-Up Stroke. Neurohospitalist (2015) 0.78
Update on Neurocritical Care of Stroke. Curr Cardiol Rep (2017) 0.75
Improving Door to Needle time in Patients for Thrombolysis. BMJ Qual Improv Rep (2016) 0.75
Use of intravenous tissue plasminogen activator and hospital costs for patients with acute ischaemic stroke aged 18-64 years in the USA. Stroke Vasc Neurol (2016) 0.75
A case-control study of the effectiveness of tissue plasminogen activator on 6 month patients--reported outcomes and health care utilization. J Stroke Cerebrovasc Dis (2014) 0.75
Thrombolysis for stroke: defining the time window. Stroke (2002) 0.75
Prehospital and intra-hospital time delays in posterior circulation stroke: results from the Austrian Stroke Unit Registry. J Neurol (2016) 0.75
Intra-arterial thrombolysis using rt-PA in patients with acute stroke due to vessel occlusion of anterior and/or posterior cerebral circulation. Neuroradiology (2007) 0.75
Stenting versus endarterectomy for treatment of carotid-artery stenosis. N Engl J Med (2010) 17.57
Endovascular therapy after intravenous t-PA versus t-PA alone for stroke. N Engl J Med (2013) 14.78
Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials. Lancet (2010) 12.21
MRI profile and response to endovascular reperfusion after stroke (DEFUSE 2): a prospective cohort study. Lancet Neurol (2012) 5.91
Safety and efficacy of NA-1 in patients with iatrogenic stroke after endovascular aneurysm repair (ENACT): a phase 2, randomised, double-blind, placebo-controlled trial. Lancet Neurol (2012) 2.34
Matrix metalloproteinase-9 in an exploratory trial of intravenous minocycline for acute ischemic stroke. Stroke (2011) 1.80
The use of flow cytometry to evaluate temporal changes in inflammatory cells following focal cerebral ischemia in mice. Brain Res (2002) 1.77
Minocycline to improve neurologic outcome in stroke (MINOS): a dose-finding study. Stroke (2010) 1.69
Health-related quality of life after carotid stenting versus carotid endarterectomy: results from CREST (Carotid Revascularization Endarterectomy Versus Stenting Trial). J Am Coll Cardiol (2011) 1.60
Transplanted stem cell-secreted vascular endothelial growth factor effects poststroke recovery, inflammation, and vascular repair. Stem Cells (2011) 1.54
Safety of stenting and endarterectomy by symptomatic status in the Carotid Revascularization Endarterectomy Versus Stenting Trial (CREST). Stroke (2011) 1.45
Visual field defect and intracerebral hemorrhage associated with use of vardenafil (Levitra). Neurology (2005) 1.43
Carotid stenting vs surgery: parsing the risk of stroke and MI. Cleve Clin J Med (2010) 1.41
Oral citicoline in acute ischemic stroke: an individual patient data pooling analysis of clinical trials. Stroke (2002) 1.24
Intracranial hemorrhage complicating carotid artery stenting and carotid endarterectomy. Stroke (2011) 1.10
Mouse model of focal cerebral ischemia using endothelin-1. J Neurosci Methods (2008) 1.06
Stroke after carotid stenting and endarterectomy in the Carotid Revascularization Endarterectomy versus Stenting Trial (CREST). Circulation (2012) 1.03
Intraarterial suction thrombectomy in acute stroke. AJNR Am J Neuroradiol (2002) 0.98
Strokes, thromboembolic events, and IVIg: rare incidents blemish an excellent safety record. Neurology (2003) 0.89
Testing for loss of protective sensation in patients with foot ulceration: a cross-sectional study. J Am Podiatr Med Assoc (2005) 0.87
Stroke: Treatment for acute stroke--the end of the citicoline saga. Nat Rev Neurol (2012) 0.85
Dabigatran etexilate: management in acute ischemic stroke. Am J Crit Care (2013) 0.83
Keep the three hour TPA window: the lost study of Atlantis. J Stroke Cerebrovasc Dis (2009) 0.81
Meta-analysis of randomized intra-arterial thrombolytic trials for the treatment of acute stroke due to middle cerebral artery occlusion. J Neurointerv Surg (2010) 0.79
781 Mbit/s photon-counting optical communications using a superconducting nanowire detector. Opt Lett (2006) 0.79
Indications and applications of arterial stents for stroke prevention in atherosclerotic intracranial stenosis. Curr Cardiol Rep (2010) 0.78
Potentiating intra-arterial sonothrombolysis for acute ischemic stroke by the addition of the ultrasound contrast agents (Optison™ & SonoVue(®)). J Thromb Thrombolysis (2011) 0.77
A comparison of cooling techniques to treat cardiac arrest patients with hypothermia. Stroke Res Treat (2011) 0.76
Association of intraprocedural blood pressure and end tidal carbon dioxide with outcome after acute stroke intervention. Neurocrit Care (2014) 0.76
Adiponectin: spectator or player? Stroke (2005) 0.75
Sonothrombolysis: an emerging modality for the treatment of acute ischemic and hemorrhagic stroke. Transl Stroke Res (2011) 0.75
Efficient performance optimization of SOA-MZI devices. Opt Express (2008) 0.75
All-optical pulse regeneration in an ultrafast nonlinear interferometer with Faraday mirror polarization stabilization. Opt Lett (2003) 0.75
Multi-aperture digital coherent combining for free-space optical communication receivers. Opt Express (2016) 0.75
High-order temporal coherences of chaotic and laser light. Opt Express (2010) 0.75
Scalable modulator for frequency shift keying in free space optical communications. Opt Express (2013) 0.75